Beijing Likang Life Science and Tech Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Beijing Likang Life Science and Tech Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability, and Immunogenicity of LK101 Alone in Participants With Incurable Solid Tumors (NCT06054932) | Beijing Likang Life Science and Tech Co., Ltd. | 2023-09-05 |
Track Beijing Likang Life Science and Tech Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.